PPBT Stock Analysis: Buy, Sell, or Hold?
PPBT - Purple Biotech Ltd. American Depositary Shares
$2.25
0.59 (35.54%)
▲
5d:
+30.05%
30d:
+49.99%
90d:
-23.73%
WAIT
LOW Confidence
Analysis Updated: Sep 1, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When PPBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PPBT is 31.6% above its trading range ($1.71). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PPBT is 31.6% above its trading range ($1.71). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PPBT is currently trading at $2.25, which is considered extended relative to its 30-day fair value range of $1.39 to $1.71.
Technical Outlook: Technically, PPBT is in a strong downtrend. The price is approaching resistance at $1.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 35.5% recently.
Market Sentiment: PPBT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.00 (+924.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PPBT is in a strong downtrend. The price is approaching resistance at $1.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 35.5% recently.
Market Sentiment: PPBT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.00 (+924.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.39 -
$1.71
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+31.6% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+35.5%)
- BULLISH: Trading 924.1% below Wall St target ($17.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.39 -
$1.71
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.47
Resistance Level
$1.80
Current Trend
Strong Downtrend
Technical data as of
Sep 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.64
Wall Street Target
$17.00
(+924.1%)
Share & Embed Analysis
Last updated: September 02, 2026 11:57 AM ET
Data refreshes hourly during market hours. Next update: 12:57 PM
Data refreshes hourly during market hours. Next update: 12:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 51 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 39 SELL |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 48 HOLD |
